Roy A Whitfield's Net Worth
Roy A Whitfield's net worth is estimated to be at least $6,766,019.00 as of 12/23/2024. CoreStreet's estimation of Roy A Whitfield's net worth is based on their sale of stock and current holding of stock.
Roy A Whitfield is Director at Nektar Therapeutics. They have executed at least 11 trades of stock as per SEC Form 4 filings. Their most recent trade was for 30,000 units of NKTR stock on 06/14/2023. Their biggest sale was on 06/05/2015 when they sold 4,500 units of Illumina Inc stock for $933,705.00. They typically trade 1 times per year.
Total value of insider buys:
- $628,250.00
Total value of insider sells:
- $6,137,769.00
Most recent insider trade:
- June 14, 2023
Roy A Whitfield's Insider Trading History
| Nektar Therapeutics | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 14, 2023 | Director | 30,000 | $0.57 | Sell | $17,100.00 |
Aug. 10, 2017 | Director | 35,000 | $17.95 | Buy | $628,250.00 |
| Illumina Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 12, 2016 | Director | 4,000 | $167.22 | Sell | $668,880.00 |
June 13, 2016 | Director | 3,800 | $140.44 | Sell | $533,672.00 |
April 12, 2016 | Director | 4,000 | $170.00 | Sell | $680,000.00 |
June 5, 2015 | Director | 4,500 | $207.49 | Sell | $933,705.00 |
April 6, 2015 | Director | 4,600 | $181.32 | Sell | $834,072.00 |
Nov. 17, 2014 | Director | 4,000 | $178.26 | Sell | $713,040.00 |
Aug. 15, 2014 | Director | 4,000 | $169.28 | Sell | $677,120.00 |
Sept. 3, 2013 | Director | 2,000 | $78.49 | Sell | $156,980.00 |
| Incyte Corporation | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 17, 2013 | Director | 40,000 | $23.08 | Sell | $923,200.00 |